146 related articles for article (PubMed ID: 19901563)
1. Overexpression of a novel gene gankyrin correlates with the malignant phenotype of colorectal cancer.
Tang S; Yang G; Meng Y; Du R; Li X; Fan R; Zhao L; Bi Q; Jin J; Gao L; Zhang L; Li H; Fan M; Wang Y; Wu K; Liu J; Fan D
Cancer Biol Ther; 2010 Jan; 9(2):88-95. PubMed ID: 19901563
[TBL] [Abstract][Full Text] [Related]
2. Gankyrin sustains PI3K/GSK-3β/β-catenin signal activation and promotes colorectal cancer aggressiveness and progression.
He F; Chen H; Yang P; Wu Q; Zhang T; Wang C; Wei J; Chen Z; Hu H; Li W; Cao J
Oncotarget; 2016 Dec; 7(49):81156-81171. PubMed ID: 27835604
[TBL] [Abstract][Full Text] [Related]
3. Gankyrin activates mTORC1 signaling by accelerating TSC2 degradation in colorectal cancer.
Qin X; Wang X; Liu F; Morris LE; Wang X; Jiang B; Zhang Y
Cancer Lett; 2016 Jun; 376(1):83-94. PubMed ID: 26975632
[TBL] [Abstract][Full Text] [Related]
4. Gankyrin oncoprotein overexpression as a critical factor for tumor growth in human esophageal squamous cell carcinoma and its clinical significance.
Ortiz CM; Ito T; Tanaka E; Tsunoda S; Nagayama S; Sakai Y; Higashitsuji H; Fujita J; Shimada Y
Int J Cancer; 2008 Jan; 122(2):325-32. PubMed ID: 17935131
[TBL] [Abstract][Full Text] [Related]
5. Gankyrin activates IL-8 to promote hepatic metastasis of colorectal cancer.
Bai Z; Tai Y; Li W; Zhen C; Gu W; Jian Z; Wang Q; Lin JE; Zhao Q; Gong W; Liang B; Wang C; Zhou T
Cancer Res; 2013 Jul; 73(14):4548-58. PubMed ID: 23576566
[TBL] [Abstract][Full Text] [Related]
6. Gankyrin promotes the proliferation of gastric cancer and is associated with chemosensitivity.
Zeng YC; Sun D; Li WH; Zhao J; Xin Y
Tumour Biol; 2017 Jun; 39(6):1010428317704820. PubMed ID: 28653901
[TBL] [Abstract][Full Text] [Related]
7. Association of gankyrin and stemness factor expression in human colorectal cancer.
Mine H; Sakurai T; Kashida H; Matsui S; Nishida N; Nagai T; Hagiwara S; Watanabe T; Kudo M
Dig Dis Sci; 2013 Aug; 58(8):2337-44. PubMed ID: 23508981
[TBL] [Abstract][Full Text] [Related]
8. Gankyrin promotes the proliferation of human pancreatic cancer.
Meng Y; He L; Guo X; Tang S; Zhao X; Du R; Jin J; Bi Q; Li H; Nie Y; Liu J; Fan D
Cancer Lett; 2010 Nov; 297(1):9-17. PubMed ID: 20483533
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor (TGF) β1 acted through miR-130b to increase integrin α5 to promote migration of colorectal cancer cells.
Yi R; Li Y; Wang F; Gu J; Isaji T; Li J; Qi R; Zhu X; Zhao Y
Tumour Biol; 2016 Aug; 37(8):10763-73. PubMed ID: 26873488
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer.
Wang WP; Yan XL; Li WM; Ni YF; Zhao JB; Lu Q; Wang XJ; Sun Y; Chen P; Yan BY; Cui Y; Zhang ZP; Li XF
Pathol Res Pract; 2015 Dec; 211(12):939-47. PubMed ID: 26554593
[TBL] [Abstract][Full Text] [Related]
11. Decreased expression of SCUBE2 is associated with progression and prognosis in colorectal cancer.
Song Q; Li C; Feng X; Yu A; Tang H; Peng Z; Wang X
Oncol Rep; 2015 Apr; 33(4):1956-64. PubMed ID: 25672935
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of REG3A in colorectal cancer cells confers proliferation and correlates with colorectal cancer risk.
Ye Y; Xiao L; Wang SJ; Yue W; Yin QS; Sun MY; Xia W; Shao ZY; Zhang H
Oncotarget; 2016 Jan; 7(4):3921-33. PubMed ID: 26646797
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-1254 inhibits the migration of colon adenocarcinoma cells by targeting PSMD10.
Chu YM; Peng HX; Xu Y; Yang DM; Zhou FL; Li J; Kuai R; Lin Y
J Dig Dis; 2017 Mar; 18(3):169-178. PubMed ID: 28296190
[TBL] [Abstract][Full Text] [Related]
14. The oncoprotein gankyrin promotes the development of colitis-associated cancer through activation of STAT3.
Sakurai T; Higashitsuji H; Kashida H; Watanabe T; Komeda Y; Nagai T; Hagiwara S; Kitano M; Nishida N; Abe T; Kiyonari H; Itoh K; Fujita J; Kudo M
Oncotarget; 2017 Apr; 8(15):24762-24776. PubMed ID: 28160571
[TBL] [Abstract][Full Text] [Related]
15. TUC.338 promotes invasion and metastasis in colorectal cancer.
Wang C; Wang Z; Zhou J; Liu S; Wu C; Huang C; Ding Y
Int J Cancer; 2017 Mar; 140(6):1457-1464. PubMed ID: 27914101
[TBL] [Abstract][Full Text] [Related]
16. Gankyrin drives metabolic reprogramming to promote tumorigenesis, metastasis and drug resistance through activating β-catenin/c-Myc signaling in human hepatocellular carcinoma.
Liu R; Li Y; Tian L; Shi H; Wang J; Liang Y; Sun B; Wang S; Zhou M; Wu L; Nie J; Lin B; Tang S; Zhang Y; Wang G; Zhang C; Han J; Xu B; Liu L; Gong K; Zheng T
Cancer Lett; 2019 Feb; 443():34-46. PubMed ID: 30503555
[TBL] [Abstract][Full Text] [Related]
17. Chronic Microcystin-LR Exposure Induces Hepatocarcinogenesis via Increased Gankyrin in Vitro and in Vivo.
He L; Huang Y; Guo Q; Zeng H; Zheng C; Wang J; Chen JA; Wang L; Shu W
Cell Physiol Biochem; 2018; 49(4):1420-1430. PubMed ID: 30205410
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of p28/gankyrin in human hepatocellular carcinoma and its clinical significance.
Fu XY; Wang HY; Tan L; Liu SQ; Cao HF; Wu MC
World J Gastroenterol; 2002 Aug; 8(4):638-43. PubMed ID: 12174370
[TBL] [Abstract][Full Text] [Related]
19. Unexpected Lower Expression of Oncoprotein Gankyrin in Drug Resistant ABCG2 Overexpressing Breast Cancer Cell Lines.
Taheri T; Jamialahmadi K; Khadijeh F
Asian Pac J Cancer Prev; 2017 Dec; 18(12):3413-3418. PubMed ID: 29286612
[TBL] [Abstract][Full Text] [Related]
20. Gankyrin promotes tumor growth and metastasis through activation of IL-6/STAT3 signaling in human cholangiocarcinoma.
Zheng T; Hong X; Wang J; Pei T; Liang Y; Yin D; Song R; Song X; Lu Z; Qi S; Liu J; Sun B; Xie C; Pan S; Li Y; Luo X; Li S; Fang X; Bhatta N; Jiang H; Liu L
Hepatology; 2014 Mar; 59(3):935-46. PubMed ID: 24037855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
